ASH 2015: First-In-Class Myeloma Highlights

A number of first-in-class products for acute myeloid leukemia and multiple myeloma provided clinical updates during the American Society for Hematology's (ASH) annual meeting, held Dec. 4-8 in Orlando, Florida.

More from Alimentary/Metabolic

More from Therapy Areas